Caprotti R, Franciosi C, Romano F, Codecasa G, Musco F, Motta M, Uggeri F
Department of General Surgical Clinic, San Gerardo Hospital, Monza, University of Milan, Italy.
Surg Laparosc Endosc Percutan Tech. 1999 Jun;9(3):203-6.
Hereditary spherocytosis is the most common red blood cell membrane disorder and often is associated with hemolytic crisis and premature cholelithiasis. Splenectomy is the only effective therapy for this disorder and often it is performed in combination with cholecystectomy. Conventional surgery requires a wide upper abdominal incision for correct exposure of the gallbladder and spleen. Laparoscopic cholecystectomy and splenectomy have been performed safely worldwide. We report our experience with seven patients (one male and six female, average age 12 years) who underwent combined laparoscopic splenectomy and cholecystectomy for hereditary spherocytosis. The patient was placed in supine position and the procedure performed with a five-trocar technique. Cholecystectomy was performed first, then splenectomy was achieved and the spleen removed by morcellation into a retrieval bag (five cases) or via a 4- to 5-cm left subcostal incision (two cases). No patient required conversion to open technique or blood transfusion. The mean blood loss was 162 mL, mean operative time 207 minutes, mean spleen size 14.5 cm, and median postoperative hospital stay 4 days. No perioperative mortality or major complications occurred in our series. After a median follow-up of 18 months all patients showed sharp hematologic improvement. Despite the small number of cases, we consider the combined laparoscopic approach safe and effective for the treatment of hereditary spherocytosis.
遗传性球形红细胞增多症是最常见的红细胞膜疾病,常与溶血性危机和过早发生的胆石症相关。脾切除术是治疗该疾病的唯一有效疗法,且常与胆囊切除术联合进行。传统手术需要在上腹部做一个大切口,以便正确暴露胆囊和脾脏。腹腔镜胆囊切除术和脾切除术已在全球范围内安全开展。我们报告了7例(1例男性和6例女性,平均年龄12岁)因遗传性球形红细胞增多症接受腹腔镜联合脾切除术和胆囊切除术患者的经验。患者取仰卧位,采用五孔技术进行手术。先进行胆囊切除术,然后进行脾切除术,脾脏通过切碎装入回收袋(5例)或经4至5厘米的左肋下切口取出(2例)。无一例患者需要转为开放手术或输血。平均失血量为162毫升,平均手术时间为207分钟,平均脾脏大小为14.5厘米,术后中位住院时间为4天。我们的系列病例中未发生围手术期死亡或重大并发症。中位随访18个月后,所有患者的血液学指标均有明显改善。尽管病例数较少,但我们认为腹腔镜联合手术治疗遗传性球形红细胞增多症安全有效。